Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+44.2%
5Y CAGR+50.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+44.2%/yr
vs +67.9%/yr prior
5Y CAGR
+50.7%/yr
Recent deceleration
Acceleration
-23.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
7.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$26.26M-24.5%
2024$34.76M+12.0%
2023$31.03M+253.9%
2022$8.77M+961.3%
2021$826000.00-75.6%
2020$3.38M-61.3%
2019$8.74M+691.9%
2018$1.10M-